GRIN2B and Cognitive impairment: In contrast, negative allosteric modulators (NAMs) of GluN2B have been shown to induce transient cognitive impairment [165] similar to the actions of NMDA receptor blockers, suggesting that GluN2B potentiation may produce an opposing effect.